The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Federico Piscione
Showing 1-5 of 5 articles
Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
De Servi S,
Crimi G,
Calabrò P,
Piscione F,
Cattaneo M,
Maffeo D,
Toso A,
Bartorelli A,
Palmieri C,
De Carlo M,
Capodanno D,
Barozzi C,
Tomasi L,
Della Riva D,
Angiolillo D,
Palmerini T
June 20, 2016 | 10.4244/EIJV12I3A51
Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials
Piccolo R,
Eitel I,
Iversen A,
Gu Y,
Dominguez-Rodriguez A,
de Smet B,
Mahmoud K,
Abreu-Gonzalez P,
Thiele H,
Piscione F
January 20, 2014
Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison
Piscione F,
Piccolo R,
Cassese S,
Galasso G,
De Rosa R,
Chiariello M,
D’Andrea C
February 25, 2010
Acute aortic syndromes at high surgical risk: the endovascular approach
Piscione F,
Sarno G,
Iannelli G,
Di Tommaso L,
Furbatto F,
D’Andrea C,
Accardo D,
Chiariello M
January 20, 2008
Percutaneous coronary interventions in Europe 1992-2003
Cook S,
Togni M,
Walpoth N,
Maier W,
Muehlberger V,
Legrand V,
Milicic D,
Zambartas C,
Zelízko M,
Madsen J-K,
van Buuren F,
López-Palop R,
Peeba M,
Koskenkorva J,
Vanhanen H,
Lablanche J,
Lazaris I,
Géza F,
Eyjolfsson K,
Kearney P,
Piscione F,
Erglis A,
Navickas R,
Beissel J,
Channam R,
Koch K,
Deleanu D,
Melberg T,
Witkowski A,
Pereira H,
Reho I,
Fridrich V,
Zorman D,
Nilsson T,
Oezmen F,
Ludman P,
Meier B
February 20, 2006
1
Latest news
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022
NEW
EuroIntervention's new Impact Factor!
June 28, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke